PRDX1 and renal carcinoma: The compound was verified to induce apoptosis in renal carcinoma cells by reducing the ROS level caused by the upregulated peroxiredoxin 1 (PRDX1) and also demonstrated potent antitumor efficacy in renal carcinoma xenograft mice [8,9].